David Hering, Invivyd CEO
Adagio adopts new name, adds Covid cocktail candidate in ‘new day’ bid after initial drug development woes
Adagio is now Invivyd.
More than just a brand name change though, the biotech is adding a new Covid-19 drug candidate and looking for a …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
